Category: ICTS News
Doug Lindsay, ICTS Community Advisory Board Co-Chair, Appointed to PCORI’s Rare Disease Advisory Panel
Lindsay to serve as co-chair for the Patient-Centered Outcomes Research Institute’s (PCORI) Advisory Panel on Rare Diseases, one of five multi-stakeholder advisory panels.
Immune modulator drugs for COVID-19 focus of major NIH clinical trial
Phase 3 trial involves hospitalized patients with moderate to severe disease
MU Team Wins Honorable Mention in NCATS “Rare Diseases Are Not Rare” Challenge
Congratulations to ICTS investigator, Jonathan Bath, MD, assistant professor of surgery at the University of Missouri-Columbia School of Medicine and medical student Danielle Kinsey on their honorable mention in the NCATS Rare Diseases Are Not Rare 2020 Challenge .
Basis of developmental disabilities focus of $11.3 million in grants
Researchers at Washington University School of Medicine in St. Louis have received a pair of grants totaling $11.3 million to study genetic and environmental factors that contribute to developmental disabilities and to find new ways to improve the lives of children and adults affected by such disabilities.
Antibodies protect against wide range of influenza B virus strains
Pieces of four antibodies (turquoise) attach to a protein from influenza B virus (gray) in the colorized cryo-electron microscopy reconstruction. Researchers at Washington University School of Medicine in St. Louis and Icahn School of Medicine at Mount Sinai have identified two antibodies that protect mice against lethal infections of influenza B virus.
CTRFP Awardee Taps ICTS Resources to Advance Research on Non-Invasive Brain Cancer Diagnosis
Trying to manage funding a lab while running a lab can be challenging for even the most experienced investigator. For Hong Chen, PhD, assistant professor of biomedical engineering at the McKelvey School of Engineering at Washington University in St. Louis and of radiation oncology at the School of Medicine, the ICTS provided invaluable assistance on […]
Clinical and Translational Research Funding Program community track awardee Rhonda BeLue, PhD, featured in St. Louis Magazine
Novel clinical trial launched to test multiple therapeutics to treat COVID-19
The Infectious Disease Clinical Research Unit at Washington University School of Medicine has launched the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which will be conducted by the AIDS Clinical Trials Group. The school’s Infectious Disease Clinical Research Unit is one of 25 initial sites conducting ACTIV-2, which includes both phase 2 and phase […]
The Foundation for Barnes-Jewish Hospital Supports COVID-19 Research
The ability of The Foundation for Barnes-Jewish Hospital to rapidly provide support for scientific research to understand the biology of this infection, and to speed the development of countermeasures—testing, treatments and vaccines—was critical in accelerating research in our laboratories and for our patients. William G. Powderly, the Dr. J. William Campbell Professor of Medicine, co-director, […]